Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil

Kinetics of sorbinil, an orally absorbed aldose reductase inhibitor, were examined in man. Peak plasma concentrations were 0.95 μg/ml after a single 50‐mg oral dose and 3.6 μg/ml after a 250‐mg dose. The apparent volume of distribution was 840 ml/kg. Elimination from plasma was slow with a terminal half life between 6 and 24 hr after dose of 34 to 52 hr and a renal clearance of 6.0 ml/min/1.73 m 2 . Administration of 50 mg/day for 5 claws induced a mean peak serum concentration of 1.9 μg/ml. A dose of 250 mg/day for 10 days induced a peak serum concentration of 10.6 μg/ml. A mean of one‐third of the dose was ultimately recovered unchanged in urine. Sorbinil kinetics make it suitable for once‐a‐day dosing. Clinical Pharmacology and Therapeutics (1981) 30, 693–700; doi: 10.1038/clpt.1981.222